RayzeBio, a wholly-owned subsidiary of Bristol Myers Squibb, is seeking a clinical development lead for its prostate cancer assets. The role will help develop and execute strategy and clinical development plans across the full lifecycle, from IND through Phase 3 registrational studies. The lead will work with research and translational medicine teams to inform development of clinical-stage assets and pipeline molecules, contribute to business development and due diligence, and partner with BMS oncology leaders on combination strategies and prostate disease-area strategy. The position may also grow and manage a prostate cancer clinical team as program needs require. The role provides clinical direction and scientific expertise for early- and late-stage programs, including IND preparation, regulatory interactions, Phase 1 through Phase 3 trial design and execution, and medical monitoring. It leads cross-functional study teams through study design, implementation, monitoring, analysis, and reporting, ensuring programs address patient needs and business objectives. The position is remote in the United States and involves approximately 30% travel.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Senior
Education Level
Ph.D. or professional degree